Cargando…

Brolucizumab-related retinal vasculitis with exacerbation following ranibizumab retreatment: A clinicopathologic case study

PURPOSE: To describe the clinical and pathologic characteristics of a case of retinal vasculitis and vitritis following brolucizumab administration and subsequent ranibizumab treatment. OBSERVATIONS: A 76-year old Caucasian woman experienced pain, decreased vision and floaters one week after receivi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iyer, Prashanth G., Peden, Marc C., Suñer, Ivan J., Patel, Nish, Dubovy, Sander R., Albini, Thomas A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695942/ https://www.ncbi.nlm.nih.gov/pubmed/33294727 http://dx.doi.org/10.1016/j.ajoc.2020.100989

Ejemplares similares

Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration
por: Haug, Sara J., et al.
Publicado: (2020)

Imaging Features of Retinal Vasculitis and/or Retinal Vascular Occlusion after Brolucizumab Treatment in the Postmarketing Setting
por: Grewal, Dilraj S., et al.
Publicado: (2023)

Evaluation of Molecular Properties versus In Vivo Performance of Aflibercept, Brolucizumab, and Ranibizumab in a Retinal Vascular Hyperpermeability Model
por: Schubert, William, et al.
Publicado: (2022)

Retinal arterial occlusive vasculitis after multiple intravitreal brolucizumab injections for diabetic macular edema
por: Hirano, Takao, et al.
Publicado: (2022)

Trends in the Cumulative Post-Marketing Reporting Rates of Retinal Vasculitis and/or Retinal Vascular Occlusion and Associated Vision Loss with Brolucizumab
por: Igwe, Franklin, et al.
Publicado: (2022)

Swept-source optical coherence tomography angiography of retinal occlusive vasculitis following brolucizumab administration: a case report
por: Lee, Eun Kyoung, et al.
Publicado: (2022)

Brolucizumab vs aflibercept and ranibizumab for neovascular age-related macular degeneration: a cost-effectiveness analysis
por: Yu, Justin S, et al.
Publicado: (2021)

RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Review of Real-World Evidence
por: Wykoff, Charles C., et al.
Publicado: (2023)

The effect of ranibizumab and aflibercept treatment on the prevalence of outer retinal tubulation and its influence on retreatment in neovascular age-related macular degeneration
por: Kovacs, Attila, et al.
Publicado: (2018)

Brolucizumab and immunogenicity
por: Sharma, Ashish, et al.
Publicado: (2020)

Retinal pigment epithelial tear following intravitreal injection of brolucizumab
por: Ashkenazy, Noy, et al.
Publicado: (2021)

Clinicopathologic Correlation of a Subretinal Proliferative Vitreoretinopathy Band in a Patient with Chronic Recurrent Retinal Detachment
por: Brown, Karen R., et al.
Publicado: (2018)

Rapid Regression of Exudative Maculopathy in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis Syndrome after Intravitreal Ranibizumab
por: Marín-Lambíes, Cristina, et al.
Publicado: (2012)

Switching to Brolucizumab in Neovascular Age-Related Macular Degeneration Incompletely Responsive to Ranibizumab or Aflibercept: Real-Life 6 Month Outcomes
por: Haensli, Christof, et al.
Publicado: (2021)

Brolucizumab for macular degeneration
Publicado: (2020)

Side Effects of Brolucizumab
por: Motevasseli, Tahmineh, et al.
Publicado: (2021)

Challenging cases discussed by experts: retinal vasculitis following coinfection with HIV and syphilis
por: Albini, Thomas, et al.
Publicado: (2011)

Erratum: Side Effects of Brolucizumab
Publicado: (2022)

The combination therapy of subtenon triamcinolone acetonide injection and intravitreal brolucizumab for brolucizumab-related intraocular inflammation
por: Shigemoto, Yumi, et al.
Publicado: (2021)

Retinal vasculitis with Chronic Recurrent Multifocal Osteomyelitis: a case report and review of the literature
por: Shanmugam, Victoria K., et al.
Publicado: (2019)

Dexamethasone Sustained-Release Intracanalicular Insert for Control of Postoperative Inflammation After Pars Plana Vitrectomy
por: Suñer, Ivan J, et al.
Publicado: (2021)

Efficacy and Safety of Brolucizumab, Aflibercept, and Ranibizumab for the Treatment of Patients with Visual Impairment Due to Diabetic Macular Oedema: A Systematic Review and Network Meta-Analysis
por: Sydnor, Shelby, et al.
Publicado: (2023)

Antibiotic Retreatment for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Sethi, Sanjay, et al.
Publicado: (2020)

Comparison of ranibizumab alone versus ranibizumab with targeted retinal laser for branch retinal vein occlusion with macular edema
por: Goel, Siddhi, et al.
Publicado: (2019)

Brolucizumab—another anti-VEGF or beyond
por: Sharma, Ashish, et al.
Publicado: (2020)

Is This a 737 Max Moment for Brolucizumab?
por: Rosenfeld, Philip J., et al.
Publicado: (2020)

Severe vision loss secondary to retinal arteriolar occlusions after multiple intravitreal brolucizumab administrations
por: Jain, Atul, et al.
Publicado: (2020)

Angiographic findings before and after the onset of brolucizumab-associated retinal vascular occlusion and intraocular inflammation
por: Kusuhara, Sentaro, et al.
Publicado: (2022)

A case of vasculitis, retinitis and macular neurosensory detachment presenting post typhoid fever
por: Relhan, Nidhi, et al.
Publicado: (2014)

An aetiological & clinicopathological study on cutaneous vasculitis
por: Khetan, Pooja, et al.
Publicado: (2012)

Monitoring Delayed Toxoplasmosis-Related Branch Retinal Artery Occlusion Using Widefield en face Optical Coherence Tomography and Multimodal Imaging
por: Iyer, Prashanth, et al.
Publicado: (2023)

Comment on: Is this a 737 Max Moment for Brolucizumab
por: Kayath, Marcia, et al.
Publicado: (2021)

Advanced Coats’ disease treated with intravitreal brolucizumab combined with laser photocoagulation
por: Patel, Nimesh A., et al.
Publicado: (2020)

Efficacy and safety of brolucizumab versus aflibercept in eyes with early persistent retinal fluid: 96-week outcomes from the HAWK and HARRIER studies
por: Lally, David R., et al.
Publicado: (2022)

Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion
por: Dogan, Emine, et al.
Publicado: (2018)

A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis
por: Arnold, Jack, et al.
Publicado: (2022)

Tozinameran: Leukocytoclastic vasculitis exacerbation: case report
Publicado: (2021)

Bilaterale Vaskulitis nach intravitrealer Gabe von Brolucizumab
por: Kessler, L. J., et al.
Publicado: (2021)

Intravitreal Brolucizumab for Choroidal Neovascularization Associated to Angioid Streaks
por: Chakraborty, Somnath, et al.
Publicado: (2022)

Gains in the current understanding of managing neovascular AMD with brolucizumab
por: Bodaghi, Bahram, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aqp0u1bufb1io3sjueeji6mdn3